NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Alafair Biosciences, Inc.

Alafair Biosciences, Inc.

Private
Austin, TexasHealthcare & Life Scienceshttps://alafairbiosciences.com/

Last Round

Series B

Apr 18, 2019

Total Funding Raised

$14.26M

Company Overview

Alafair Biosciences, Inc. is a medical device company that develops and commercializes a portfolio of products based on its proprietary hydrogel technology designed to improve patient outcomes by enhancing internal wound healing and protecting soft tissues after surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

hydrogel implantmedical devicepost-surgical adhesionsbioresorbable barrieranti-adhesion productsoft tissue protectionadhesion barriertendon repairsurgical barriersurgical biomaterialsorthopedic surgeryperipheral nerve surgerysurgical filmbiotech medical

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alafair Biosciences, Inc. Comps

Public and private peers based on sector, stage, and business model.

Alafair Biosciences, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alafair Biosciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 18, 2019
VC RoundOct 19, 2018
Convertible DebtJul 19, 2017
Series AAug 10, 2016
GrantMay 16, 2014
Seed
Sep 10, 2013

Key People

Founding team and executive leadership

John Joyoprayitno

President CEO Co-founder

Founding Team

Bhushan Holay

Chief Financial Officer

Executive Team

Alafair Biosciences, Inc. Investors

Notable investors and investment history

Alafair Biosciences, Inc. investors
InvestorRounds
UT SystemSeries A
ATP FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 7, 2025

    Ranked #2 on the 2025 Longhorn 100 list.

Alafair Biosciences, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alafair Biosciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alafair Biosciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range61
Year Founded2011
Last FundingApr 18, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.